Mechanism of Action: Iron Chelating Activity
✉ Email this page to a colleague
Drugs with Mechanism of Action: Iron Chelating Activity
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alembic | DEFERASIROX | deferasirox | TABLET;ORAL | 211824-001 | Nov 20, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Stevens J | DEFERASIROX | deferasirox | TABLET;ORAL | 210727-002 | Dec 27, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Zydus Pharms | DEFERASIROX | deferasirox | TABLET;ORAL | 211383-001 | Nov 20, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sun Pharm | DEFERASIROX | deferasirox | TABLET;ORAL | 211641-001 | Jan 2, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Alkem Labs Ltd | DEFERASIROX | deferasirox | TABLET;ORAL | 210555-002 | Mar 30, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Msn | DEFERASIROX | deferasirox | TABLET, FOR SUSPENSION;ORAL | 209878-002 | Nov 20, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Msn | DEFERASIROX | deferasirox | GRANULE;ORAL | 214650-001 | Mar 17, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
